GWSG
ABUS icon

GPS Wealth Strategies Group’s Arbutus Biopharma ABUS Stock Holding History

GPS Wealth Strategies Group’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-700
Closed -$2.12K – 1243
2023
Q1 		$2.12K Buy
+700
New +$1.98K ﹤0.01% 1115
2022
Q4 		– Sell
-700
Closed -$1K – 125
2022
Q3 		$1K Hold
700
– – ﹤0.01% 1061
2022
Q2 		$2K Sell
700
-1,165
-62% -$2.98K ﹤0.01% 1003
2022
Q1 		$6K Sell
1,865
-500
-21% -$1.53K ﹤0.01% 810
2021
Q4 		$9K Hold
2,365
– – ﹤0.01% 745
2021
Q3 		$10K Hold
2,365
– – ﹤0.01% 706
2021
Q2 		$7K Sell
2,365
-1,000
-30% -$3.1K ﹤0.01% 796
2021
Q1 		$11K Buy
+3,365
New +$13K ﹤0.01% 650

Other funds holding ABUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return